{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T13:14:28Z","timestamp":1792329268929,"version":"4.4.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000090","name":"United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["PC200390, PC210168"],"award-info":[{"award-number":["PC200390, PC210168"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA285772-01"],"award-info":[{"award-number":["1R01CA285772-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["2023CHAL4150"],"award-info":[{"award-number":["2023CHAL4150"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002337","name":"Petre Foundation","doi-asserted-by":"publisher","award":["Chair"],"award-info":[{"award-number":["Chair"]}],"id":[{"id":"10.13039\/501100002337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["YJ20210053"],"award-info":[{"award-number":["YJ20210053"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Prostate cancer (PCa) is highly heritable, with men of African ancestry at greatest risk and associated lethality. Lack of representation in genomic data means germline testing guidelines exclude for Africans. Established that structural variations (SVs) are major contributors to human disease and prostate tumourigenesis, their role is under-appreciated in familial and therapeutic testing. Utilising clinico-methodologically matched deep-sequenced whole-genome data for 113 African\n                    <jats:italic>versus<\/jats:italic>\n                    57 European PCa patients, we interrogate 42,966 high-quality germline SVs using a best-fit pathogenicity prediction workflow. We identify 15 potentially pathogenic SVs representing 12.4% African and 7.0% European patients, of which 72% and 86% met germline testing standard-of-care recommendations, respectively. Notable African-specific loss-of-function gene candidates include DNA damage repair\n                    <jats:italic>MLH1<\/jats:italic>\n                    and\n                    <jats:italic>BARD1<\/jats:italic>\n                    and tumour suppressors\n                    <jats:italic>FOXP1, WASF1<\/jats:italic>\n                    and\n                    <jats:italic>RB1<\/jats:italic>\n                    . Representing only a fraction of the vast African diaspora, this study raises considerations with respect to the contribution of kilo-to-mega-base rare variants to PCa pathogenicity and African-associated disparity.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-57312-9","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T19:00:21Z","timestamp":1741633221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Rare pathogenic structural variants show potential to enhance prostate cancer germline testing for African men"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5907-2445","authenticated-orcid":false,"given":"Tingting","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0920-8310","authenticated-orcid":false,"given":"Jue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korawich","family":"Uthayopas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3975-2333","authenticated-orcid":false,"given":"M. S. Riana","family":"Bornman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazzem","family":"Gheybi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0934-0656","authenticated-orcid":false,"given":"Phillip D.","family":"Stricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3917-5524","authenticated-orcid":false,"given":"Joachim","family":"Weischenfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingai B. A.","family":"Mutambirwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weerachai","family":"Jaratlerdsiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4524-7280","authenticated-orcid":false,"given":"Vanessa M.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"57312_CR1","doi-asserted-by":"crossref","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 74, 229\u2013263 (2024).","DOI":"10.3322\/caac.21834"},{"key":"57312_CR2","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1158\/1055-9965.EPI-13-0568","volume":"23","author":"J. B Hjelmborg","year":"2014","unstructured":"Hjelmborg, J. B, et al. The heritability of prostate cancer in the nordic twin study of cancer. Cancer Epidemiol. Biomarkers Prev. 23, 2303\u20132310 (2014).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"57312_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-017-0724-5","volume":"18","author":"Z. L Smith","year":"2017","unstructured":"Smith, Z. L., Eggener, S. E. & Murphy, A. B. African-American prostate cancer disparities. Curr. Urol. Rep. 18, 81 (2017).","journal-title":"Curr. Urol. Rep."},{"key":"57312_CR4","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1177\/1557988318798279","volume":"12","author":"H. E Taitt","year":"2018","unstructured":"Taitt, H. E. Global trends and prostate cancer: A review of incidence, detection, and mortality as influenced by race, rthnicity, and geographic location. Am. J. Mens Health 12, 1807\u20131823 (2018).","journal-title":"Am. J. Mens Health"},{"key":"57312_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3322\/caac.21718","volume":"72","author":"A. N Giaquinto","year":"2022","unstructured":"Giaquinto, A. N. et al. Cancer statistics for African American\/Black People 2022. Cancer J. Clin.72, 202\u2013229 (2022).","journal-title":"Cancer J. Clin."},{"key":"57312_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.euo.2021.07.006","volume":"5","author":"B. A Mahal","year":"2022","unstructured":"Mahal, B. A. et al. Prostate cancer racial disparities: A systematic review by the prostate cancer foundation panel. Eur. Urol. Oncol. 5, 18\u201329 (2022).","journal-title":"Eur. Urol. Oncol."},{"key":"57312_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.eururo.2021.04.013","volume":"80","author":"B. F Darst","year":"2021","unstructured":"Darst, B. F. et al. Combined effect of a polygenic risk score and rare genetic variants on prostate cancer risk. Eur. Urol. 80, 134\u2013138 (2021).","journal-title":"Eur. Urol."},{"key":"57312_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.eururo.2022.12.021","volume":"83","author":"T. M Seibert","year":"2023","unstructured":"Seibert, T. M. et al. Genetic risk prediction for prostate cancer: Implications for early detection and prevention. Eur. Urol. 83, 241\u2013248 (2023).","journal-title":"Eur. Urol."},{"key":"57312_CR9","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","volume":"382","author":"J de Bono","year":"2020","unstructured":"de Bono, J. et al. Olaparib for metastatic castration-resistant prostate cancer. N. Engl. J. Med. 382, 2091\u20132102 (2020).","journal-title":"N. Engl. J. Med."},{"key":"57312_CR10","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1200\/JCO.20.01035","volume":"38","author":"W Abida","year":"2020","unstructured":"Abida, W. et al. Rucaparib in men with metastatic castration-resistant prostate cancer harboring a BRCA1 or BRCA2 gene alteration. J. Clin. Oncol. 38, 3763\u20133772 (2020).","journal-title":"J. Clin. Oncol."},{"key":"57312_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41416-020-01114-x","volume":"124","author":"R Lozano","year":"2021","unstructured":"Lozano, R. et al. Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancer. Br. J. Cancer 124, 552\u2013563 (2021).","journal-title":"Br. J. Cancer"},{"key":"57312_CR12","unstructured":"National Comprehensive Cancer Network Clinical Guidelines in Oncology (NCCN Guidelines\u00ae): Prostate Cancer (Version 4.2023)."},{"key":"57312_CR13","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1200\/JCO.20.00046","volume":"38","author":"V. N Giri","year":"2020","unstructured":"Giri, V. N. et al. Implementation of germline testing for prostate cancer: Philadelphia prostate cancer consensus conference 2019. J. Clin. Oncol. 38, 2798\u20132811 (2020).","journal-title":"J. Clin. Oncol."},{"key":"57312_CR14","doi-asserted-by":"publisher","first-page":"e784","DOI":"10.1200\/OP.22.00634","volume":"19","author":"L. G Briggs","year":"2023","unstructured":"Briggs, L. G. et al. Racial differences in germline genetic testing for prostate cancer: A systematic review. J. Oncol. Pract. 19, e784\u2013e793 (2023).","journal-title":"J. Oncol. Pract."},{"key":"57312_CR15","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1056\/NEJMc2000069","volume":"383","author":"B. A Mahal","year":"2020","unstructured":"Mahal, B. A. et al. Racial differences in genomic profiling of prostate cancer. N. Engl. J. Med. 383, 1083\u20131085 (2020).","journal-title":"N. Engl. J. Med."},{"key":"57312_CR16","doi-asserted-by":"publisher","first-page":"e473","DOI":"10.1093\/oncolo\/oyad042","volume":"28","author":"L. F Valle","year":"2023","unstructured":"Valle, L. F. et al. Actionable genomic alterations in prostate cancer among black and white united states veterans. Oncologist 28, e473\u2013e477 (2023).","journal-title":"Oncologist"},{"key":"57312_CR17","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1158\/2767-9764.CRC-22-0136","volume":"2","author":"J. A White","year":"2022","unstructured":"White, J. A. et al. Whole-exome sequencing of Nigerian prostate tumors from the prostate cancer transatlantic consortium (CaPTC) reveals DNA repair genes associated with African ancestry. Cancer Res. Commun. 2, 1005\u20131016 (2022).","journal-title":"Cancer Res. Commun."},{"key":"57312_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41586-022-05154-6","volume":"609","author":"W Jaratlerdsiri","year":"2022","unstructured":"Jaratlerdsiri, W. et al. African-specific molecular taxonomy of prostate cancer. Nature 609, 552\u2013559 (2022).","journal-title":"Nature"},{"key":"57312_CR19","doi-asserted-by":"publisher","DOI":"10.1200\/PO.22.00234","volume":"6","author":"V. N Giri","year":"2022","unstructured":"Giri, V. N., Hartman, R., Pritzlaff, M., Horton, C. & Keith, S. W. Germline variant spectrum among African American men undergoing prostate cancer germline testing: Need for equity in genetic testing. J. Precis. Oncol. 6, e2200234 (2022).","journal-title":"J. Precis. Oncol."},{"key":"57312_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.6004\/jnccn.2022.7097","volume":"21","author":"K Gheybi","year":"2023","unstructured":"Gheybi, K. et al. Evaluating germline testing panels in Southern African males with advanced prostate cancer. J. Natl. Compr. Cancer Netw. 21, 289\u2013296.e283 (2023).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"57312_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.eururo.2023.04.006","volume":"84","author":"P. X. Y Soh","year":"2023","unstructured":"Soh, P. X. Y. & Hayes, V. M. Common genetic variants associated with prostate cancer risk: The need for African inclusion. Eur. Urol. 84, 22\u201324 (2023).","journal-title":"Eur. Urol."},{"key":"57312_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43726-w","volume":"14","author":"P. X. Y Soh","year":"2023","unstructured":"Soh, P. X. Y. et al. Prostate cancer genetic risk and associated aggressive disease in men of African ancestry. Nat. Commun. 14, 8037 (2023).","journal-title":"Nat. Commun."},{"key":"57312_CR23","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/pros.22806","volume":"74","author":"E. A Tindall","year":"2014","unstructured":"Tindall, E. A. et al. Clinical presentation of prostate cancer in Black South Africans. Prostate 74, 880\u2013891 (2014).","journal-title":"Prostate"},{"key":"57312_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1200\/PO.19.00179","volume":"4","author":"M Matejcic","year":"2020","unstructured":"Matejcic, M. et al. Pathogenic variants in cancer predisposition genes and prostate cancer risk in men of African ancestry. J. Precis. Oncol. 4, 32\u201343 (2020).","journal-title":"J. Precis. Oncol."},{"key":"57312_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJMoa1603144","volume":"375","author":"C. C Pritchard","year":"2016","unstructured":"Pritchard, C. C. et al. Inherited DNA-repair gene mutations in men with metastatic prostate cancer. N. Engl. J. Med. 375, 443\u2013453 (2016).","journal-title":"N. Engl. J. Med."},{"key":"57312_CR26","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","volume":"163","author":"The Cancer Genome Atlas Research N","year":"2015","unstructured":"The Cancer Genome Atlas Research N. The molecular taxonomy of primary prostate cancer. Cell 163, 1011\u20131025 (2015).","journal-title":"Cell"},{"key":"57312_CR27","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3389\/fonc.2019.01287","volume":"9","author":"M. J Ryan","year":"2019","unstructured":"Ryan, M. J. & Bose, R. Genomic alteration burden in advanced prostate cancer and therapeutic implications. Front. Oncol. 9, 1287\u20131287 (2019).","journal-title":"Front. Oncol."},{"key":"57312_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01096-w","volume":"14","author":"T Gong","year":"2022","unstructured":"Gong, T. et al. Genome-wide interrogation of structural variation reveals novel African-specific prostate cancer oncogenic drivers. Genome Med. 14, 100 (2022).","journal-title":"Genome Med."},{"key":"57312_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01240-0","volume":"15","author":"A. T Pagnamenta","year":"2023","unstructured":"Pagnamenta, A. T. et al. Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases. Genome Med. 15, 94 (2023).","journal-title":"Genome Med."},{"key":"57312_CR30","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/s41436-020-0880-8","volume":"22","author":"M. L Thibodeau","year":"2020","unstructured":"Thibodeau, M. L. et al. Improved structural variant interpretation for hereditary cancer susceptibility using long-read sequencing. Genet Med. 22, 1892\u20131897 (2020).","journal-title":"Genet Med."},{"key":"57312_CR31","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41431-023-01284-1","volume":"31","author":"K Dixon","year":"2023","unstructured":"Dixon, K. et al. Defining the heterogeneity of unbalanced structural variation underlying breast cancer susceptibility by nanopore genome sequencing. Eur. J. Hum. Genet. 31, 602\u2013606 (2023).","journal-title":"Eur. J. Hum. Genet."},{"key":"57312_CR32","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-020-2287-8","volume":"581","author":"R. L Collins","year":"2020","unstructured":"Collins, R. L. et al. A structural variation reference for medical and population genetics. Nature 581, 444\u2013451 (2020).","journal-title":"Nature"},{"key":"57312_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-019-0514-7","volume":"12","author":"S.-J Park","year":"2019","unstructured":"Park, S.-J., Yoon, B.-H., Kim, S.-K. & Kim, S.-Y. GENT2: an updated gene expression database for normal and tumor tissues. BMC Med. Genomics 12, 101 (2019).","journal-title":"BMC Med. Genomics"},{"key":"57312_CR34","doi-asserted-by":"publisher","first-page":"e1720","DOI":"10.1210\/clinem\/dgad312","volume":"108","author":"K Pellikaan","year":"2023","unstructured":"Pellikaan, K. et al. Malignancies in prader-willi syndrome: results from a large international cohort and literature review.  J. Clin. Endocrinol. Metab. 108, e1720\u2013e1730 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"57312_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.555630","volume":"7","author":"S De Summa","year":"2020","unstructured":"De Summa, S. et al. The genetic germline background of single and multiple primary melanomas. Front. Mol. Biosci. 7, 555630 (2020).","journal-title":"Front. Mol. Biosci."},{"key":"57312_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25408-6","volume":"8","author":"D Cole-Clark","year":"2018","unstructured":"Cole-Clark, D. et al. An initial melanoma diagnosis may increase the subsequent risk of prostate cancer: Results from the New South Wales Cancer Registry. Sci. Rep. 8, 7167 (2018).","journal-title":"Sci. Rep."},{"key":"57312_CR37","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature11935","volume":"494","author":"R. A Burrell","year":"2013","unstructured":"Burrell, R. A. et al. Replication stress links structural and numerical cancer chromosomal instability. Nature 494, 492\u2013496 (2013).","journal-title":"Nature"},{"key":"57312_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-98218-y","volume":"11","author":"E. K Teye","year":"2021","unstructured":"Teye, E. K. et al. PIGN spatiotemporally regulates the spindle assembly checkpoint proteins in leukemia transformation and progression. Sci. Rep. 11, 19022 (2021).","journal-title":"Sci. Rep."},{"key":"57312_CR39","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.7150\/thno.18005","volume":"7","author":"Y Jiang","year":"2017","unstructured":"Jiang, Y. et al. Cysteine transporter SLC3A1 promotes breast cancer tumorigenesis. Theranostics 7, 1036\u20131046 (2017).","journal-title":"Theranostics"},{"key":"57312_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton, A. et al. A global reference for human genetic variation. Nature 526, 68\u201374 (2015).","journal-title":"Nature"},{"key":"57312_CR41","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1016\/j.cell.2022.08.004","volume":"185","author":"M Byrska-Bishop","year":"2022","unstructured":"Byrska-Bishop, M. et al. High-coverage whole-genome sequencing of the expanded 1000 Genomes Project cohort including 602 trios. Cell 185, 3426\u20133440.e3419 (2022).","journal-title":"Cell"},{"key":"57312_CR42","doi-asserted-by":"publisher","unstructured":"Jun G., et al. Structural variation across 138,134 samples in the TOPMed consortium. Preprint at https:\/\/doi.org\/10.1101\/2023.01.25.525428 (2023).","DOI":"10.1101\/2023.01.25.525428"},{"key":"57312_CR43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ajhg.2021.12.007","volume":"109","author":"A. G Sharo","year":"2022","unstructured":"Sharo, A. G., Hu, Z., Sunyaev, S. R. & Brenner, S. E. StrVCTVRE: A supervised learning method to predict the pathogenicity of human genome structural variants.  Am. J. Hum. Genet. 109, 195\u2013209 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"57312_CR44","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1101\/gr.275995.121","volume":"32","author":"P Kleinert","year":"2022","unstructured":"Kleinert, P. & Kircher, M. A framework to score the effects of structural variants in health and disease. Genome Res. 32, 766\u2013777 (2022).","journal-title":"Genome Res."},{"key":"57312_CR45","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1093\/nar\/gkad225","volume":"51","author":"V S\u00e1nchez-Gaya","year":"2023","unstructured":"S\u00e1nchez-Gaya, V. & Rada-Iglesias, A. POSTRE: a tool to predict the pathological effects of human structural variants. Nucleic Acids Res. 51, e54\u2013e54 (2023).","journal-title":"Nucleic Acids Res."},{"key":"57312_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43651-y","volume":"14","author":"Z Xu","year":"2023","unstructured":"Xu, Z., Li, Q., Marchionni, L. & Wang, K. PhenoSV: interpretable phenotype-aware model for the prioritization of genes affected by structural variants. Nat. Commun. 14, 7805 (2023).","journal-title":"Nat. Commun."},{"key":"57312_CR47","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"57312_CR48","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","volume":"18","author":"Z Sondka","year":"2018","unstructured":"Sondka, Z. et al. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers. Nat. Rev. Cancer 18, 696\u2013705 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"57312_CR49","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/s41588-021-00949-1","volume":"53","author":"P Srinivasan","year":"2021","unstructured":"Srinivasan, P. et al. The context-specific role of germline pathogenicity in tumorigenesis. Nat. Genet. 53, 1577\u20131585 (2021).","journal-title":"Nat. Genet."},{"key":"57312_CR50","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1101\/gr.180281.114","volume":"24","author":"G Ha","year":"2014","unstructured":"Ha, G. et al. TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data. Genome Res. 24, 1881\u20131893 (2014).","journal-title":"Genome Res."},{"key":"57312_CR51","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1158\/0008-5472.CAN-17-0337","volume":"77","author":"J. T Robinson","year":"2017","unstructured":"Robinson, J. T., Thorvaldsdottir, H., Wenger, A. M., Zehir, A. & Mesirov, J. P. Variant Review with the Integrative Genomics Viewer. Cancer Res. 77, e31\u2013e34 (2017).","journal-title":"Cancer Res."},{"key":"57312_CR52","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1073\/pnas.1519959113","volume":"113","author":"S Nagamori","year":"2016","unstructured":"Nagamori, S. et al. Novel cystine transporter in renal proximal tubule identified as a missing partner of cystinuria-related plasma membrane protein rBAT\/SLC3A1. Proc. Natl. Acad. Sci. USA 113, 775\u2013780 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57312_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-017-3913-1","volume":"18","author":"H. J Martell","year":"2017","unstructured":"Martell, H. J. et al. Associating mutations causing cystinuria with disease severity with the aim of providing precision medicine. BMC Genomics 18, 550 (2017).","journal-title":"BMC Genomics"},{"key":"57312_CR54","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1046\/j.1468-3083.2003.00767.x","volume":"17","author":"J. F Okulicz","year":"2003","unstructured":"Okulicz, J. F., Shah, R. S., Schwartz, R. A. & Janniger, C. K. Oculocutaneous albinism. J. Eur. Acad. Dermatol. Venereol. 17, 251\u2013256 (2003).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"57312_CR55","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/bjd.17917","volume":"181","author":"M. R Roberts","year":"2019","unstructured":"Roberts, M. R., Asgari, M. M. & Toland, A. E. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet? Br. J. Dermatol. 181, 1146\u20131155 (2019).","journal-title":"Br. J. Dermatol."},{"key":"57312_CR56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.gene.2018.01.100","volume":"651","author":"X. P Li","year":"2018","unstructured":"Li, X. P. et al. OCA2 rs4778137 polymorphism predicts survival of breast cancer patients receiving neoadjuvant chemotherapy. Gene 651, 161\u2013165 (2018).","journal-title":"Gene"},{"key":"57312_CR57","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/ajmg.a.37369","volume":"170a","author":"L Fleming","year":"2016","unstructured":"Fleming, L. et al. Genotype-phenotype correlation of congenital anomalies in multiple congenital anomalies hypotonia seizures syndrome (MCAHS1)\/PIGN-related epilepsy. Am. J. Med. Genet. A 170a, 77\u201386 (2016).","journal-title":"Am. J. Med. Genet. A"},{"key":"57312_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.106033","volume":"196","author":"A Jezela-Stanek","year":"2020","unstructured":"Jezela-Stanek, A., Mierzewska, H. & Szczepanik, E. Vertical nystagmus as a feature of PIGN-related glycosylphosphatidylinositol biosynthesis defects. Clin. Neurol. Neurosurg. 196, 106033 (2020).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"57312_CR59","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/25292","volume":"396","author":"C Lengauer","year":"1998","unstructured":"Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643\u2013649 (1998).","journal-title":"Nature"},{"key":"57312_CR60","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/gim.2013.193","volume":"16","author":"S Haraldsdottir","year":"2014","unstructured":"Haraldsdottir, S. et al. Prostate cancer incidence in males with Lynch syndrome. Genet. Med. 16, 553\u2013557 (2014).","journal-title":"Genet. Med."},{"key":"57312_CR61","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.3390\/cancers14184381","volume":"14","author":"H Cai","year":"2022","unstructured":"Cai, H. et al. In Vivo Application of CRISPR\/Cas9 revealed implication of Foxa1 and Foxp1 in prostate cancer proliferation and epithelial plasticity. Cancers14, 4381 (2022).","journal-title":"Cancers"},{"key":"57312_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-022-00291-7","volume":"6","author":"K. M Dillon","year":"2022","unstructured":"Dillon, K. M. et al. PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer. Npj Precis. Oncol. 6, 49 (2022).","journal-title":"Npj Precis. Oncol."},{"key":"57312_CR63","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","volume":"373","author":"J Zhang","year":"2015","unstructured":"Zhang, J. et al. Germline mutations in predisposition genes in pediatric cancer. N. Engl. J. Med. 373, 2336\u20132346 (2015).","journal-title":"N. Engl. J. Med."},{"key":"57312_CR64","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","volume":"173","author":"K.-l Huang","year":"2018","unstructured":"Huang, K.-l et al. Pathogenic germline variants in 10,389 adult cancers. Cell 173, 355\u2013370 (2018).","journal-title":"Cell"},{"key":"57312_CR65","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nature23306","volume":"548","author":"D. R Robinson","year":"2017","unstructured":"Robinson, D. R. et al. Integrative clinical genomics of metastatic cancer. Nature 548, 297\u2013303 (2017).","journal-title":"Nature"},{"key":"57312_CR66","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","volume":"116","author":"W Abida","year":"2019","unstructured":"Abida, W. et al. Genomic correlates of clinical outcome in advanced prostate cancer. Proc. Natl. Acad. Sci. USA 116, 11428\u201311436 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57312_CR67","doi-asserted-by":"publisher","first-page":"12383","DOI":"10.18632\/oncotarget.3564","volume":"6","author":"A. G Sowalsky","year":"2015","unstructured":"Sowalsky, A. G. et al. Loss of Wave1 gene defines a subtype of lethal prostate cancer. Oncotarget 6, 12383\u201312391 (2015).","journal-title":"Oncotarget"},{"key":"57312_CR68","doi-asserted-by":"publisher","first-page":"13281","DOI":"10.18632\/aging.103433","volume":"12","author":"T Sun","year":"2020","unstructured":"Sun, T., Bi, F., Liu, Z. & Yang, Q. SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer. Aging12, 13281\u201313296 (2020).","journal-title":"Aging"},{"key":"57312_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-01023-x","volume":"21","author":"S Jiang","year":"2023","unstructured":"Jiang, S. et al. Lower SLC7A2 expression is associated with enhanced multidrug resistance, less immune infiltrates and worse prognosis of NSCLC. Cell Commun. Signal. 21, 9 (2023).","journal-title":"Cell Commun. Signal."},{"key":"57312_CR70","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neo.2018.06.008","volume":"20","author":"F Alessandrini","year":"2018","unstructured":"Alessandrini, F., Pezz\u00e8, L., Menendez, D., Resnick, M. A. & Ciribilli, Y. ETV7-Mediated DNAJC15 repression leads to doxorubicin resistance in breast cancer cells. Neoplasia 20, 857\u2013870 (2018).","journal-title":"Neoplasia"},{"key":"57312_CR71","doi-asserted-by":"publisher","first-page":"219","DOI":"10.7150\/jca.79236","volume":"14","author":"J Huang","year":"2023","unstructured":"Huang, J. et al. The role of CTNNA1 in malignancies: An updated review. J. Cancer 14, 219\u2013230 (2023).","journal-title":"J. Cancer"},{"key":"57312_CR72","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s13238-015-0234-5","volume":"7","author":"H Zhang","year":"2016","unstructured":"Zhang, H. et al. Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer. Protein Cell 7, 141\u2013151 (2016).","journal-title":"Protein Cell"},{"key":"57312_CR73","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1007\/s43032-021-00584-5","volume":"28","author":"R Huang","year":"2021","unstructured":"Huang, R. et al. Co-expression analysis of genes and tumor-infiltrating immune cells in metastatic uterine carcinosarcoma. Reprod. Sci. 28, 2685\u20132698 (2021).","journal-title":"Reprod. Sci."},{"key":"57312_CR74","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.18632\/oncotarget.13716","volume":"8","author":"H JingSong","year":"2017","unstructured":"JingSong, H. et al. siRNA-mediated suppression of collagen type iv alpha 2 (COL4A2) mRNA inhibits triple-negative breast cancer cell proliferation and migration. Oncotarget 8, 2585\u20132593 (2017).","journal-title":"Oncotarget"},{"key":"57312_CR75","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ejhg.2012.20","volume":"20","author":"E Verbeek","year":"2012","unstructured":"Verbeek, E. et al. COL4A2 mutation associated with familial porencephaly and small-vessel disease. Eur. J. Hum. Genet. 20, 844\u2013851 (2012).","journal-title":"Eur. J. Hum. Genet."},{"key":"57312_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.896297","volume":"10","author":"J Groenendyk","year":"2022","unstructured":"Groenendyk, J. et al. Loss of the fructose transporter SLC2A5 inhibits cancer cell migration. Front. Cell Dev. Biol. 10, 896297 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"57312_CR77","doi-asserted-by":"crossref","unstructured":"Porubsky, D. & Eichler, E. E. A 25-year odyssey of genomic technology advances and structural variant discovery. Cell 187, 1024\u20131037 (2024).","DOI":"10.1016\/j.cell.2024.01.002"},{"key":"57312_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47993-x","volume":"13","author":"K Gheybi","year":"2023","unstructured":"Gheybi, K. et al. Linking African ancestral substructure to prostate cancer health disparities. Sci. Rep. 13, 20909 (2023).","journal-title":"Sci. Rep."},{"key":"57312_CR79","doi-asserted-by":"publisher","first-page":"144","DOI":"10.22465\/juo.244800340017","volume":"22","author":"V. M Hayes","year":"2024","unstructured":"Hayes, V. M. et al. Health equity research outcomes and improvement consortium prostate cancer health precision Africa1K: Closing the health equity gap through rural community inclusion. J. Urol. Oncol. 22, 144\u2013149 (2024).","journal-title":"J. Urol. Oncol."},{"key":"57312_CR80","unstructured":"Sadsad, R., Samaha, G. & Chew, T. Fastq-to-bam @ NCI-Gadi [Internet].). WorkflowHub (2021)."},{"key":"57312_CR81","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/bioinformatics\/btv710","volume":"32","author":"X Chen","year":"2016","unstructured":"Chen, X. et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics 32, 1220\u20131222 (2016).","journal-title":"Bioinformatics"},{"key":"57312_CR82","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1101\/gr.222109.117","volume":"27","author":"D. L Cameron","year":"2017","unstructured":"Cameron, D. L. et al. GRIDSS: sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly. Genome Res. 27, 2050\u20132060 (2017).","journal-title":"Genome Res."},{"key":"57312_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02423-x","volume":"22","author":"D. L Cameron","year":"2021","unstructured":"Cameron, D. L. et al. GRIDSS2: comprehensive characterisation of somatic structural variation using single breakend variants and structural variant phasing. Genome Biol. 22, 202 (2021).","journal-title":"Genome Biol."},{"key":"57312_CR84","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"A. R Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"57312_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13341-9","volume":"10","author":"H. P Eggertsson","year":"2019","unstructured":"Eggertsson, H. P. et al. GraphTyper2 enables population-scale genotyping of structural variation using pangenome graphs. Nat. Commun. 10, 5402 (2019).","journal-title":"Nat. Commun."},{"key":"57312_CR86","doi-asserted-by":"publisher","first-page":"D988","DOI":"10.1093\/nar\/gkab1049","volume":"50","author":"F Cunningham","year":"2022","unstructured":"Cunningham, F. et al. Ensembl 2022. Nucleic Acids Res. 50, D988\u2013D995 (2022).","journal-title":"Nucleic Acids Res."},{"key":"57312_CR87","doi-asserted-by":"publisher","first-page":"bax028","DOI":"10.1093\/database\/bax028","volume":"2017","author":"S Fishilevich","year":"2017","unstructured":"Fishilevich, S. et al. GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database 2017, bax028 (2017).","journal-title":"Database"},{"key":"57312_CR88","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1093\/bioinformatics\/btac409","volume":"38","author":"E. K Gustavsson","year":"2022","unstructured":"Gustavsson, E. K., Zhang, D., Reynolds, R. H., Garcia-Ruiz, S. & Ryten, M. ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2. Bioinformatics 38, 3844\u20133846 (2022).","journal-title":"Bioinformatics"},{"key":"57312_CR89","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"P Danecek","year":"2021","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).","journal-title":"Gigascience"},{"key":"57312_CR90","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa056","volume":"22","author":"T Gong","year":"2021","unstructured":"Gong, T., Hayes, V. M. & Chan, E. K. F. Detection of somatic structural variants from short-read next-generation sequencing data. Brief. Bioinform. 22, bbaa056 (2021).","journal-title":"Brief. Bioinform."},{"key":"57312_CR91","doi-asserted-by":"publisher","first-page":"D936","DOI":"10.1093\/nar\/gks1213","volume":"41","author":"I Lappalainen","year":"2013","unstructured":"Lappalainen, I. et al. DbVar and DGVa: public archives for genomic structural variation. Nucleic Acids Res. 41, D936\u2013D941 (2013).","journal-title":"Nucleic Acids Res."},{"key":"57312_CR92","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"M. J Landrum","year":"2018","unstructured":"Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062\u2013D1067 (2018).","journal-title":"Nucleic Acids Res."},{"key":"57312_CR93","unstructured":"Andrews, S. FastQC: a quality control tool for high throughput sequence data. Available at: http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc (2010)."},{"key":"57312_CR94","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels, P., Magnusson, M., Lundin, S. & K\u00e4ller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047\u20133048 (2016).","journal-title":"Bioinformatics"},{"key":"57312_CR95","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1093\/bioinformatics\/bts611","volume":"28","author":"E Kopylova","year":"2012","unstructured":"Kopylova, E., No\u00e9, L. & Touzet, H. SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data. Bioinformatics 28, 3211\u20133217 (2012).","journal-title":"Bioinformatics"},{"key":"57312_CR96","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590\u2013D596 (2013).","journal-title":"Nucleic Acids Res."},{"key":"57312_CR97","doi-asserted-by":"publisher","first-page":"D192","DOI":"10.1093\/nar\/gkaa1047","volume":"49","author":"I Kalvari","year":"2021","unstructured":"Kalvari, I. et al. Rfam 14: expanded coverage of metagenomic, viral and microRNA families. Nucleic Acids Res. 49, D192\u2013D200 (2021).","journal-title":"Nucleic Acids Res."},{"key":"57312_CR98","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"57312_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"M. I Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"57312_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-28218-7","volume":"13","author":"D Sheerin","year":"2023","unstructured":"Sheerin, D. et al. Identification and control for the effects of bioinformatic globin depletion on human RNA-seq differential expression analysis. Scientific Rep. 13, 1859 (2023).","journal-title":"Scientific Rep."},{"key":"57312_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-024-10208-2","volume":"25","author":"E Orcel","year":"2024","unstructured":"Orcel, E. et al. A single workflow for multi-species blood transcriptomics. BMC Genomics 25, 282 (2024).","journal-title":"BMC Genomics"},{"key":"57312_CR102","doi-asserted-by":"publisher","unstructured":"Gong T. StructuralVariantUtil. GitHub, https:\/\/doi.org\/10.5281\/zenodo.14642422 (2024).","DOI":"10.5281\/zenodo.14642422"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57312-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57312-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57312-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T06:58:03Z","timestamp":1741676283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57312-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57312"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57312-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4531885\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"5 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interest, that V.M.H. is a Member of Active Surveillance Movember Committee. The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2400"}}